Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06500299
What this trial is testing

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Who this might be right for
Overweight and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180
Not applicableLooking for participantsNCT07625202
What this trial is testing

Creatine Supplementation During GLP-1a Therapy

Who this might be right for
Sarcopenia
University of Saskatchewan 40
Testing effectiveness (Phase 2)Looking for participantsNCT06582875
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyObesity
University of Colorado, Denver 126
Testing effectiveness (Phase 2)UnknownNCT04615910
What this trial is testing

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

Who this might be right for
Diabetes Mellitus
Radboud University Medical Center 30
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Not applicableStudy completedNCT03923114
What this trial is testing

Imaging Pituitary ActiVation by Exendin

Who this might be right for
Diabetes Mellitus, Type 2
Radboud University Medical Center 20
Not applicableActive Not RecruitingNCT06715514
What this trial is testing

Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

Who this might be right for
MenopauseType 2 Diabetes
Lia Bally 96
Not applicableStudy completedNCT01162499
What this trial is testing

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

Who this might be right for
Postprandial Hypoglycemia
Diva De Leon 7
Large-scale testing (Phase 3)Study completedNCT05260021
What this trial is testing

Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Who this might be right for
Type2 DiabetesDiabetes MellitusDiabetes Mellitus, Type 2+5 more
Eli Lilly and Company 99
Not applicableStudy completedNCT05078255
What this trial is testing

The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObesity
Asger Lund, MD 61
Not applicableLooking for participantsNCT07293325
What this trial is testing

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Who this might be right for
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine 66
Early research (Phase 1)Study completedNCT00393445
What this trial is testing

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Who this might be right for
Hyperglycemia
Ludwig-Maximilians - University of Munich 6
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Testing effectiveness (Phase 2)Looking for participantsNCT05938712
What this trial is testing

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipients
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Very early researchEnrolling By InvitationNCT07092605
What this trial is testing

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Who this might be right for
LongevityQuality of LifeMood+5 more
AgelessRx 150
Not applicableNot Yet RecruitingNCT06546384
What this trial is testing

GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

Who this might be right for
AdiposityFatty LiverAlcohol Use Disorder
Insel Gruppe AG, University Hospital Bern 64
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Post-approval studies (Phase 4)UnknownNCT05005741
What this trial is testing

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Who this might be right for
Diabetes Mellitus, Type 2Overweight or Obesity
Second Xiangya Hospital of Central South University 120
Next Page